Exelixis
EXEL
#1725
Rank
C$13.65 B
Marketcap
$47.83
Share price
-1.16%
Change (1 day)
53.35%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Cost to borrow shares

Latest borrow fee for Exelixis (EXEL) shares on Interactive Brokers: 0.3622% (annualized)

Shares available to borrow: 4900000

The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.

Exelixis (EXEL) - cost to borrow in the last 7 days chart

Exelixis (EXEL) - number of shares available to borrow in the last 7 days

Exelixis (EXEL) - cost to borrow from 2024 to 2023

Exelixis (EXEL) - number of shares available to borrow from 2024 to 2023

Cost to borrow for shares of similar companies or competitors

Company Cost to borrow (% year) Shares available Country
1.1519%1 M๐Ÿ‡ฌ๐Ÿ‡ง UK
0.4081%3.4 M๐Ÿ‡ซ๐Ÿ‡ท France
0.4474%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4081%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4208%4.6 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.25%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
0.4182%10 M๐Ÿ‡บ๐Ÿ‡ธ USA
2.7618%0.45 M๐Ÿ‡บ๐Ÿ‡ธ USA